Hadlima

Hadlima (adalimumab-bwwd) is used to treat rheumatoid, psoriatic and juvenille idiopathic arthritis, ankylosing spondylitis, Crohn's disease, plaque psoriasis, hidradenitis suppurativa, uveitis and ulcerative colitis. Hadlima is a biosimilar for humira (adalimumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Hadlima may be covered by your Medicare or insurance plan, but some pharmacy coupons or cash prices could help offset the cost.

With the Patient Assistance Program from Organon, receive your prescription at no cost if you are eligible.